Self-representation in the thymus: An extended view

Nature Reviews Immunology

Volumn 4, Issue 9, 2004, Pages 688-698

  Kyewski, Bruno ^a   Derbinski, Jens ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CRYSTALLIN; AUTOANTIGEN; C REACTIVE PROTEIN; CHOLINERGIC RECEPTOR; COLLAGEN TYPE 2; CYTOCHROME P450; DESMOGLEIN 3; FETAL ANTIGEN; GLUTAMATE DECARBOXYLASE; GLUTATHIONE TRANSFERASE; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; INTRINSIC FACTOR; LYMPHOTOXIN; LYMPHOTOXIN BETA; MELAN A; MELANOMA ANTIGEN 1; MONOPHENOL MONOOXYGENASE; MYELIN BASIC PROTEIN; PROTEIN S100B; PROTEOLIPID PROTEIN; RETINA S ANTIGEN; RNA; T LYMPHOCYTE RECEPTOR; THYMIC STROMA LYMPHOPOIETIN; THYROGLOBULIN; THYROID PEROXIDASE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADDISON DISEASE; ANTIGEN EXPRESSION; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOIMMUNITY; CELL SPECIFICITY; DNA MICROARRAY; EPIGENETICS; EPITHELIUM CELL; GENE EXPRESSION; HASHIMOTO DISEASE; HUMAN; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MALE INFERTILITY; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NONHUMAN; PEMPHIGUS VULGARIS; PERNICIOUS ANEMIA; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; THYMOCYTE; THYMUS; TISSUE SPECIFICITY; TUMOR; UVEITIS; VARIABLE NUMBER OF TANDEM REPEAT; VITILIGO;

ANIMALS; AUTOANTIGENS; CELL DIFFERENTIATION; CLONAL DELETION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; IMMUNE TOLERANCE; THYMUS GLAND;

EID: 4544258485     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1436     Document Type: Review

References (123)

1. Ehrlich, P. & Morgenroth, J. II. Ueber Hämolysine. Berl. Klin. Wochenschr. 28, 251-257 (1901).
2. Hood, L. E., Weissman, I. L., Wood, W. B. & Wilson, J. H. Immunology. 2nd edn. (The Benjamin/Cummings Publishing Company, Inc., Palo Alto, 1978).
3. Klein, J. Immunology: The Science of Self-Nonself Discrimination. (John Wiley, New York, 1982).
4. Schwartz, R. H. & Mueller, D. L. in Fundamental Immunology 5th edn (ed. Paul, W. E.) 901-934 (Lippincott Williams & Wilkins, Philadelphia, 2003).
5. Medzhitov, R. & Janeway, C. A. Jr. Innate immunity, the virtues of a nonclonal system of recognition. Cell 91, 295-298 (1997).
6. Klein, L. & Kyewski, B. Self-antigen presentation by thymic stromal cells: a subtle division of labor. Curr. Opin. Immunol. 12, 179-186 (2000).
7. Alferink, J., Aigner, S., Reibke, R., Hämmering, G. J. & Arnold, B. Peripheral T cell tolerance: the contribution of permissive T cell migration into parenchymal tissues of the neonate. Immunol. Rev. 169, 255-261 (1999).
8. Walker, L. S. & Abbas, A. K. The enemy within: keeping self-reactive T cells at bay in the periphery. Nature Rev. Immunol. 2, 11-19 (2002).
9. Derbinski, J., Schulte, A., Kyewski, B. & Klein, L. Promiscuous gene expression in medullary thymic epethelial cells mirrors the peripheral self. Nature Immunol. 2, 1032-1039 (2001).
10. Gotter, J., Brors, B., Hergenhahn, M. & Kyewski, B. Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes co-localized in chromosomal clusters. J. Exp. Med. 199, 155-166 (2004). References 9 and 10 define and describe the phenomenon of promiscuous gene expression by purified mouse and human TEC subsets, addressing the expression pattern, scope and co-localization in chromosomal clusters of promiscuously expressed genes.
11. Sospedra, M. et al. Transcription of a broad range of self-antigens in human thymus suggests a role for central mechanisms in tolerance toward peripheral antigens. J. Immunol. 161, 5918-5929 (1998).
12. Bruno, R. et al. Multiple sclerosis candidate autoantigens except myelin oligodendrocyte glycoprotein are transcribed in human thymus. Eur. J. Immunol. 32, 2737-2747 (2002).
13. Bruno, R. et al. Different patterns of nicotinic acetylcholine receptor subunit transcription in human thymus. J. Neuroimmunol. 149, 147-159 (2004).
14. Kyewski, B., Derbinski, J., Gotter, J. & Klein, L. Promiscuous gene expression and central T-cell tolerance: more than meets the eye. Trends Immunol. 23, 364-371 (2002).
15. Mathis, D. & Benoist, C. Back to central tolerance. Immunity 20, 509-516 (2004).
16. Heid, H. W., Moll, I. & Franke, W. W. Patterns of expression of trychocytic and epithelial cytokeratins in mammalian tissue. II. Concomitant and mutually exclusive synthesis of trychocytic and epithelial cytokeratins in diverse human and bovine tissues (hair follicle, nail bed, and matrix, lingua papilla, thymic reticulum). Differentiation 37, 215-230 (1988).
17. Kirchner, T. et al. Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors. Am. J. Pathol. 130, 268-280 (1988).
18. Jolicoeur, C., Hanahan, D. & Smith, K. M. T-cell tolerance toward a transgenic β-cell antigen and transcription of endogenous pancreatic genes in thymus. Proc. Natl Acad. Sci. USA 91, 6707-6711 (1994). This paper shows transcription of several self-antigens of the exocrine and endocrine pancreas in the mouse thymus and for the first time promotes the notion that ectopic expression of tissue-restricted antigens is a physiological property of thymic stromal cells.
19. Pribyl, T. M., Campagnoni, C., Kampf, K., Handley, V. W. & Campagnoni, A. T. The major myelin protein genes are expressed in the human thymus. J. Neurosci. Res. 45, 812-819 (1996).
20. Geenen, V. & Lefebre, P. J. The intrathymic expression of insulin-related genes: implications for pathophysiology and prevention of type 1 diabetes. Diabetes Metab. Rev. 14, 95-110 (1998).
21. van Herrath, M. G., Dockter, D. & Oldstone. M. B. How virus induces a rapid or slow onset insulin-dependant diabetes mellitus in a transgenic model. Immunity 1, 231-242 (1994).
22. Smith, K. M., Olson, D. C., Hirose, R. & Hanahan, D. Pancreatic gene expression in rare cells of thymic medulla: evidence for functional contribution to T cell tolerance. Int. Immunol. 9, 1355-1365 (1997).
23. Salmon, A. M., Bruand, C., Cardona, A., Changeux, J. P. & Benin-Aknin, S. An acetylcholine receptor á subunit promoter confers intrathymic expression in transgenic mice. Implications for tolerance of a transgenic self-antigen and for autoreactivity in myasthenia gravis. J. Clin. Invest. 101, 2340-2350 (1988).
24. Antonia, S. J., Geiger, T., Miller, J. & Flavell, R. A. Mechanisms of immune tolerance induction through the thymic expression of a peripheral tissue-specific protein. Int. Immunol. 7, 715-725 (1994).
25. + T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium. J. Exp. Med. 188, 5-16 (1998).
26. Visan, L. et al. Tolerance induction by intrathymic expressin of PO. J. Immunol. 172, 1364-1370 (2004).
27. Ham, D. I. et al. Central immunotolerance in transgenic mice expressing a foreign antigen under control of the rhodopsin promotor. Invest. Ophthalmol. Vis. Sci. 45, 857-862 (2004).
28. Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045 (1994).
29. Volkmann, A., Zal, T. & Stockinger, B. Antigen-presenting cells in the thymus that can negatively select MHC class II-restricted T cells recognizing a circulating self antigen. J. Immunol. 158, 693-706 (1997).
30. Boehm, T., Scheu, S., Pfeffer, K. & Bleul, C. C. Thymic medullary epithelial cell differentiation, thymocyte emigration, and the control of autoimmunity require lympho-epithelial cross talk via LTβR. J. Exp. Med. 198, 757-769 (2003).
31. Alonso, L. & Fuchs, E. Stem cells of the skin epithelium. Proc. Natl Acad. Sci. USA 100, 11830-11835 (2003).
32. Booth, C. & Rotten, C. S. Gut instincts: thoughts on intestinal epithelial stem cells. J. Clin. Invest. 105, 1493-1499 (2000).
33. Kamath, A. T., Henri, S., Battye, F., Tough, D. F. & Shortman, K. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 100, 1734-1741 (2002).
34. Farr, A. G. & Rudensky, A. Medullary thymic epithelium: a mosaic of epithelial 'self'? J. Exp. Med. 188, 1-4 (1998).
35. Farr, A. G., Dooley, J. L. & Erickson, M. Organization of thymic medullary epithelial heterogeneity: implications for mechanisms of epithelial differentiation. Immunol. Rev. 189, 20-27 (2002). A discussion of two competing models possibly underlying promiscuous gene expression, the differentiation model and the mosaic model. The presence of 'islands' of lung epithelium and thyroid follicles in the mouse thymic medulla are interpreted as evidence for the mosaic model.
36. Chin, R. K. et al. Lymphotoxin pathway directs thymic This expression. Nature Immunol. 4, 1121-1127 (2003). This report shows that triggering of LTβR upregulates Aire gene expression by TECs in vivo and in vitro, thereby identifying Aire as a downstream target of this signalling pathway and providing a first clue to its molecular regulation.
37. Chentoufi, A. A. & Polychronakos, C. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 51, 1383-1390 (2002).
38. Langbein, L. et al. Tight junction-related structures in the absence of a lumen: occluding, claudins and tight junction plaque proteins in densely packed cell formations of stratified epithelia and squamous cell carcinomas. Eur. J. Cell Biol. 82, 385-400 (2003).
39. Chentoufi, A. A., Palumbo, M. & Polychronakos, C. Proinsulin expression by Hassall's corpuscles in the mouse thymus. Diabetes 53, 354-359 (2004).
40. Pitkanen, J. & Peterson, P. Autoimmune regulator: from loss of function to autoimmunity. Genes Immun. 4, 12-21 (2003).
41. Anderson, M. S. et al. Projection of an immunological self-shadow within the thymus by the aire protein. Science 298, 1395-1401 (2002). This paper shows that the transcriptional regulator AIRE directs the expression of many promiscuously expressed genes and that its deletion leads to a multi-organ autoimmune syndrome similar to APS-1 in humans.
42. Liston, A., Lesage, S., Wilson, J., Peltonen, L. & Goodnow, C. C. Aire regulates negative selection of organ-specific T cells. Nature Immunol. 4, 350-354 (2003). These authors show that AIRE directs the expression of a neo-self antigen under the control of the rat insulin promoter in a transgenic model and that in the absence of AIRE, deletion of antigen-specific T cells is abolished.
43. Kumar, P. G. et al. The autoimmune regulator (Aire) is a DNA-binding protein. J. Biol. Chem. 276, 41357-41364 (2001).
44. Kajiura, F. et al. NF-κB-inducing kinase establishes self-tolerance in a thymic stroma-dependent manner. J. Immunol. 172, 2067-2075 (2004).
45. + T cell homeostatic expansion. Nature Immunol. 5, 426-434 (2004).
46. Pugliese, A. et al. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nature Genet. 15, 293-297 (1997).
47. Vafiadis, P. et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nature Genet. 15, 289-292 (1997). References 46 and 47 describe a correlation between allelic forms of a genomic region upstream of the insulin promoter (the VNTR-/DDM2 locus), expression levels of Insulin in the human thymus and susceptibility to type 1 diabetes mellitus, thereby establishing a link between intrathymic expression levels of a tissue-restricted antigen and susceptibility to organ-specific autoimmunity.
48. Venanzi, E., Anderson, M. S., Johnnidis, J., Benoist, C. & Mathis, D. Aire influences peripheral antigen expression and the development of autoimmunity. (Keystone Symposia, T Cell Development, 10-15 February 2004) Abstract 334 (Banff, Alberta, Canada).
49. Schonrich, G., Momburg, F., Hammerling, G. J. & Arnold, B. Anergy induced by thymic medullary epihelium. Eur. J. Immunol. 22, 1687-1691 (1992).
50. Bonomo, A. & Matzinger, P. Thymus epithelium induces tissue-specific tolerance. J. Exp. Med. 177, 1153-1154 (1993).
51. Hoffmann, M. W., Allison, J. & Miller, J. F. Tolerance induction by thymic epithelium. Proc. Natl Acad. Sci. USA 89, 2526-2530 (1992).
52. Sprent J., Kosaka, H., Gao, E. K., Surh, C, D. & Webb, S. R. Intrathymic and extrathymic tolerance in bone marrow chimeras. Immunol. Rev. 133, 151-176 (1993).
53. Hoffmann, M. W., Heath, W. R., Ruschmeyer, D. & Miller, J. F. Deletion of high-avidity T cells by thymic epithelium. Proc. Natl Acad. Sci. USA 92, 9851-9855 (1995).
54. Avichezer, D. et al. An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms. J. Exp. Med. 198, 1665-1676 (2003).
55. Klein, L., Roettinger, B. & Kyewski, B. Sampling of complementing self-antigen pools by thymic stromal cells maximizes the scope of central T cell tolerance. Eur. J. Immunol. 31, 2476-2486 (2001).
56. Scollay, R. & Godfrey, D. I. Thymic emigration: conveyor belts or lucky dips? Immunol. Today 16, 268-273 (1995).
57. + T cell priming by dendritic cells in intact lymph nodes. Nature Immunol. 4, 579-585 (2003).
58. Witt. C. M. & Robey, E. Characterizing thymocyte migration in an intact thymus using two-photon laser-scanning microscopy. (Keystone Symposia, T Cell Development, 10-15 February 2004) Late abstract (Banff, Alberta, Canada).
59. Bleul, C. C. & Boehm, T. Chemokines define distinct microenvironments in the developing thymus. Eur. J. Immunol. 30, 3371-3379 (2000).
60. Annunziato, F., Romagnani, P., Cosmi, L., Lazzeri, E. & Romagnani, S. Chemokines and lymphopoiesis in human thymus. Trends Immunol. 22, 277-281 (2001).
61. Kwan, J. & Killeen, N. CCR7 directs the migration of thymocytes into the thymic medulla. J. Immunol. 172, 3999-4007 (2004).
62. Bajenoff, M., Granjeaud, S. & Guerder, S. The strategy of T cell antigen-presenting cell encounter in antigen-draining lymph nodes revealed by imaging of initial T cell activation. J. Exp. Med. 198, 715-724 (2003).
63. Zhang, M. et al. T cell tolerance to a neo-self antigen expressed by thymic epithelial cells: the soluble form is more effective than the membrane-bound form. J. Immunol. 170, 3954-3962 (2003). This report supports the concept of 'antigen-spreading' from mTECs to DCs by showing that a soluble form of a neo-self antigen produced by mTECs is more effective in deleting autoreactive thymocytes than a membrane-bound form.
64. Gallegos, A. & Sevan, M. Requirements for antigen presentation in central tolerance to tissue-specific antigens. (Keystone Symposia, T Cell Development, 10-15 February 2004) Abstract 211 (Banff, Alberta, Canada).
65. Muller, V. & Bonhoeffer, S. Quantitative constraints on the scope of negative selection. Trends Immunol. 24, 132-135 (2003).
66. Anderson, A. C. & Kuchroo, V. K. Expression of self-antigen in the thymus: a little goes a long way. J. Exp. Med. 198, 1627-1629 (2003).
67. Le Douarin, N. et al. Evidence for a thymus-dependent form of tolerance that is not based on elimination or anergy of reactive T cells. Immunol. Rev. 149, 35-53 (1996). This review summarizes pioneering studies in the chicken/quail model and in mice by showing that TECs confer transferable tolerance to various non-haematopoietic tissues.
68. Modigliani, Y., Bandeira, A. & Coutinho, A. A model for developmentally acquired thymus-dependent tolerance to central and peripheral antigens. Immunol. Rev. 149, 155-174 (1996).
69. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562 (2004).
70. - immunoregulatory T cells. J. Exp. Med. 194, 427-438 (2001).
71. + regulatory T cells induced by an agonist self-peptide. Nature Immunol. 2, 301-306 (2001).
72. Reg cells.
73. Ramsey, C. et al. Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum. Mol. Genet. 11, 397-409 (2002).
74. + T regulatory cells. Nature Immunol. 4, 337-342 (2003).
75. + regulatory T cells. Nature Immunol. 4, 330-336 (2003).
76. Schluesener, H. J. & Wekerle, H. Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations. J. Immunol. 135, 3128-3133 (1985).
77. + T cell subset that inhibits this autoimmune potential. J. Exp. Med. 177, 627-636 (1993).
78. Wucherpfennig, K. W. et al. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J. Immunol. 152, 5581-5592 (1994).
79. + regulatory cells? Immunity 14, 399-406 (2001).
80. Vogel, A., Strassburg, C. P., Obermayer-Straub, P., Brabant, G. & Manns, M. P. The genetic background of autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy and its autoimmune disease components. J. Mol. Med. 80, 201-211 (2002).
81. Soderbergh, A. et al. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type 1. J. Clin. Endocrinol. Metab. 89, 557-562 (2004).
82. Viglietta, V., Kent, S. C., Orban, T. & Hafler, D. A. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. J. Clin. Invest. 109, 895-903 (2002).
83. Lernmark, A. Controlling the controls: GAD65 autoreactive T cells in type 1 diabetes. J. Clin. Invest. 109, 869-870 (2002).
84. Baekkeskov, S., Knaani, J., Jaume, J. C. & Kash, S. Does GAD have a unique role in triggering IDDM? J. Autoimmun. 15, 279-286 (2000).
85. Egwuagu, C. E., Charukamnoetkanok, P. & Gery, I. Thymic expression of autoantigens correlates with resistance to autoimmune disease. J. Immunol. 159, 3109-3112 (1997). One of the first reports to show clearly in different species an inverse relationship between intrathymic expression levels of tissue-restricted self-antigens and susceptibility to experimental organ-specific autoimmune diseases.
86. Liu, H. et al. Mice resistant to experimental autoimmune encephalomyelitis have increased thymic expression of myelin basic protein and increased MBP specific T cell tolerance. J. Neuroimmunol. 115, 118-126 (2001).
87. Miyamoto, K., Miyake, S., Schachner, M. & Yamamura, T. Heterozygous null mutation of myelin P0 protein enhances susceptibility to autoimmune neuritis targeting P0 peptide. Eur. J. Immunol. 33, 656-665 (2003).
88. Thebault-Baumont, K. et al. Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. J. Clin. Invest 111, 851-857 (2003). References 87 and 88 show that a reduction in the expression level of promiscuously expressed self-antigens tilts the balance towards autoimmunity under experimental conditions.
89. Klein, L., Klugmann, M., Nave, K. A., Tuohy, V. K. & Kyewski, B. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nature Med. 6, 56-61 (2000).
90. Anderson, A. C. et al. High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoire. J. Exp. Med. 191, 761-770 (2000). Both references 89 and 90 show that self-tolerance to PLP is limited to the shorter splice variant of PLP (DM20) due to its predominant expression by TECs. This finding illustrates an inherent pitfall in central tolerance by promiscuous gene expression as a consequence of differential mRNA splicing between TECs and tissue cells.
91. Tuohy, V. K. et al. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 164, 93-100 (1998).
92. Talib, S., Okarma, T. B. & Lebkowski, J. S. Differential expression of human nicotinic acetycholine receptor á subunit variants in muscle and non-muscle tissues. Nucleic Acids Res. 21, 233-237 (1993).
93. Diez, J. et al. Differential splicing of the IA-2 mRNA in pancreas and lymphoid organs as a permissive genetic mechanism for autoimmunity against the IA-2 type 1 diabetes autoantigen. Diabetes 50, 895-900 (2001).
94. Backlund, J. et al. Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis. Eur. J. Immunol. 32, 3776-3784 (2002).
95. Boon, T. & Old, L. J. Cancer tumor antigens. Curr. Opin. Immunol. 9, 681-683 (1997).
96. Coulie, P. G. Cancer immunotherapy with MAGE antigens. Suppl. Tumori. 1, S63-S65 (2002).
97. Renkvist, N., Castelli, C., Robbins, P. F. & Parmiani, G. A listing of human tumor antigens recognized by T cells. Cancer Immunol. Immunother. 50, 3-15 (2001)
98. Diekman, A. B. et al. Anti-sperm antibodies from infertile patients and their cognate sperm antigens: a review. Identity between SAGA-1, the H6-3C4 antigen, and CD52. Am. J. Reprod. Immunol. 43, 134-143 (2000).
99. Bellgrau, D. & Duke, R. C. Apoptosis and CD95 ligand in immune privileged sites. Int. Rev. Immunol. 18, 547-562 (1999).
100. Rijnkels, M., Wheeler, D. A., de Boer, H. A. & Reper, F. R. Structure and expression of the mouse casein locus. Mamm. Genome 8, 9-15 (1997).
101. Bonney, E. A. & Matzinger, P. The maternal immune system's interaction with circulating fetal cells. J. Immunol. 158, 40-47 (1997).
102. von Boehmer, H. et al. Thymic selection revisited: how essential is it? Immunol. Rev. 191, 62-78 (2003).
103. Gauwerky, C. E. & Grace, C. M. Chromosomal translocations in leukaemia. Semin. Cancer Biol. 4, 333-340 (1993).
104. Mills, K. D., Ferguson, D. O. & Alt, F. W. The role of DNA breaks in genomic instability and tumorigenesis. Immunol. Rev. 194, 77-95 (2003).
105. Muller-Hermelink, H. K. & Marx, A. Thymoma. Curr. Opin. Oncol. 12, 426-433 (2000).
106. Jackson-Grusby, L. et al. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nature Genet. 27, 31-39 (2001).
107. Petrie, H. T. Cell migration and the control of post-natal T-cell lymphopoiesis in the thymus. Nature Rev. Immunol. 3, 859-866 (2003).
108. Nelson, A. J., Hosier, S., Brady, W., Linsley, P. S. & Fan, A. G. Medullary thymic epithelium expresses a ligand for CTLA4 in situ and in vitro. J. Immunol. 151, 2453-2461 (1993).
109. Surh, C. D. et al. Two subsets of epithelial cells in the thymic medulla. J. Exp. Med. 176, 495-505 (1992).
110. Blackburn, C. C. & Manley, N. R. Developing a new paradigm for thymus organogenesis. Nature Rev. Immunol. 4, 278-289 (2004).
111. Humblet, C., Rudensky, A. & Kyewski, B. Presentation and intercellular transfer of self-antigen within the thymic microenvironment: expression of the Eα peptide-I-Ab complex by isolated thymic stromal cells. Int. Immunol. 6, 1949-1958 (1994).
112. Scheinecker, C., McHugh, R., Shevach, E. M. & Germain, R. N. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 196, 1013-1016 (2002).
113. Ten, S., New, M. & Maclaren, N. Clinical review 130: Addison's disease 2001. J. Clin. Endocrinol. Metab. 86, 2909-2922 (2001).
114. +-ATPase T-cell epitopes in human autoimmune gastritis. Eur. J. Immunol. 33, 539-545 (2003).
115. Gery, L., Nussenblatt, R. B., Chan, C. C. & Caspi, R. R. in The Molecular Pathology of Autoimmune Diseases. 2nd edn (eds Theofilopoulos, A. N. & Bona, C. A.) 978 (Taylor & Francis, New York, 2002).
116. Vaidya, B., Kendall-Taylor, P. & Pearce, S. H. S. The Genetics of autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 87, 5385-5397 (2002).
117. Steinman, L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85, 299-302 (1996).
118. Vincent, A. Unravelling the pathogenesis of myasthenia gravis. Nature Rev. Immunol. 2, 797-804 (2002).
119. Amagai, M., Klaus-Kovtun, V. & Stanley, J. R. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67, 869-877 (1991).
120. Backlund, J. et al. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 99, 9960-9965 (2002).
121. Tisch, R. & McDevitt, H. Insulin-dependent diabetes mellitus. Cell 85, 291-297 (1996).
122. Palermo, B. et al. Specific cytotoxic lymphocyte responses against MelanA/MART1, tyrosinase and gp 100 in vitiligo by the use of major histocompatibility complex-peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo. J. Invest. Dermatol. 117, 326-332 (2001).
123. Mandelcorn-Monson, R. L. et al. Cytotoxic T lymphocyte reactivity to gp100, MelanA/Mart-1, and tyrosinase, in HLA-A2-positive vitiligo patients. J. Invest. Dermatol. 121, 550-556 (2003).